These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3112093)
1. In-vitro susceptibility of oral streptococci to pristinamycin. Maskell JP; Williams JD J Antimicrob Chemother; 1987 May; 19(5):585-90. PubMed ID: 3112093 [TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin. Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD Infection; 1988; 16(6):365-70. PubMed ID: 3146552 [TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic-resistant oral streptococci in dental patients susceptible to infective endocarditis. Longman LP; Pearce PK; McGowan P; Hardy P; Martin MV J Med Microbiol; 1991 Jan; 34(1):33-7. PubMed ID: 1990136 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae. Lozniewski A; Lion C; Mory F; Weber M Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory and fatal activity of amoxicillin, erythromycin and josamycin against Streptococci]. Savoia D; Angeretti A G Batteriol Virol Immunol; 1981; 74(7-12):283-96. PubMed ID: 7347699 [TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis. Weber P; Dubois S; Boussougant Y J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487 [TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of RP 59500 against gram-positive cocci. Goto S; Miyazaki S; Kaneko Y J Antimicrob Chemother; 1992 Jul; 30 Suppl A():25-8. PubMed ID: 1399947 [TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis]. Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of in vitro activity of pristinamycin against Haemophilus influenzae]. Dabernat H Pathol Biol (Paris); 1993 Sep; 41(7):641-6. PubMed ID: 8255616 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus. Mutton KJ; Andrew JH Chemotherapy; 1983; 29(3):218-24. PubMed ID: 6409520 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of pristinamycin on respiratory bacteria]. Leclercq R Presse Med; 1999 Sep; 28 Suppl 1():6-9. PubMed ID: 10506876 [TBL] [Abstract][Full Text] [Related]
16. Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics. Meylan PR; Francioli P; Glauser MP Antimicrob Agents Chemother; 1986 Mar; 29(3):418-23. PubMed ID: 3717942 [TBL] [Abstract][Full Text] [Related]
17. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics. Drabu YJ; Mehtar S; Blakemore PH Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250 [TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. Brumfitt W; Hamilton-Miller JM; Shah S J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948 [TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. Pechère JC J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945 [TBL] [Abstract][Full Text] [Related]
20. Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin. Maskell JP; Sefton AM; Cannell H; Kerawala C; Seymour A; Sun ZM; Williams JD J Antimicrob Chemother; 1990 Oct; 26(4):539-48. PubMed ID: 2254223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]